Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxime Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthetic route for epirubicin hydrochloride via chiral reduction. Offers high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Novel 3-step route replaces Pd/C hydrogenation, offering higher yield and lower cost for reliable pharmaceutical intermediate supply chains.
Patent CN1181053C details a high-fidelity synthesis of 3-(7-amidino-2-naphthyl) derivatives, ensuring optical purity for thrombin inhibitor manufacturing.
Novel preparation method for 4'-epidaunorubicin intermediate ensures high purity and stability. Optimized for commercial scale-up and cost reduction in pharmaceutical manufacturing.